Oncoshot
PrivateLast Round
Pre Seed
Jul 14, 2022
Total Funding Raised
$3.27M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Oncoshot is a health technology company that provides a federated AI-powered health insights exchange platform to match cancer patients with clinical trials.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Healthcare Analytics, Patient Engagement, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oncoshot Comparables
Compare Oncoshot with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Massive Bio | 79% | |
| Carebox Healthcare Solutions | 78% | |
| Inspirata, Inc. | 78% | |
Oncoshot Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Jul 14, 2022 |
Oncoshot Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Milltrust International Group | Pre Seed |
| MassMutual Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 23, 2026
Grew 17% QoQ from 18 to 21 employees.
Oncoshot Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Oncoshot's valuation, stock price, and market status.